Evidence map›Paper›PMID 41922472›Full record

ArticleScientific reports2026

ResTransUNet: a dual-encoder hybrid network for automated liver segmentation in CT scans.

Yuan Wang

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Yuan WangThe School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Scotland, AB24 3FX, UK. swwy20230@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Precise delineation of the liver is essential for effective diagnosis and treatment planning in hepatocellular carcinoma, yet current clinical practices rely heavily on manual annotation, which is both inefficient and susceptible to human error. In this work, we propose a fully automated segmentation framework, termed ResTransUNet, that leverages the complementary strengths of convolutional operations and self-attention mechanisms. The architecture introduces a bifurcated encoder design wherein spatially local features are captured through convolutional layers, while long-range dependencies are simultaneously modeled using a Transformer-based path. To bridge these parallel streams, we incorporate a feature refinement module that infuses the globally aware Transformer representations into the CNN-derived features, thereby enhancing contextual comprehension without incurring excessive computational cost. This hybrid strategy addresses the limitations commonly observed in conventional U-Net structures-particularly the inability to capture global semantics-and avoids the high complexity often associated with pure Transformer models. Extensive experimentation on the LiTS2017 benchmark reveals that the proposed model achieves superior segmentation accuracy, reporting a Dice score of 0.9535, a volumetric overlap error of 0.0804, and a relative volume difference of -0.0007. Additional validation across diverse public datasets, including 3Dircadb, CHAOS, and Sliver07, demonstrates the model's consistent generalization and robustness, particularly in challenging scenarios involving small, fragmented, or poorly contrasted liver regions.

Indexed as

Carcinoma, HepatocellularImage Processing, Computer-AssistedLiverLiver NeoplasmsTomography, X-Ray ComputedAlgorithmsConvolutional Neural NetworksHumansAttention mechanismConvolutional neural networksCT scansDeep learningHybrid networkLiver segmentationMedical image analysisResTransUNetTransformerU-Net

Identifiers

PMID41922472
PMCPMC13183919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.